BlackRock’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-1,465,265
| Closed | -$200M | – | 5160 |
|
|
2018
Q2 | $200M | Buy |
1,465,265
+90,921
| +7% | +$8.26M | 0.01% | 1459 |
|
|
2018
Q1 | $108M | Sell |
1,374,344
-39,622
| -3% | -$2.92M | 0.01% | 1788 |
|
|
2017
Q4 | $96.4M | Sell |
1,413,966
-28,731
| -2% | -$1.49M | ﹤0.01% | 1906 |
|
|
2017
Q3 | $58M | Buy |
1,442,697
+50,775
| +4% | +$1.96M | ﹤0.01% | 2203 |
|
|
2017
Q2 | $55.3M | Buy |
1,391,922
+56,383
| +4% | +$2.06M | ﹤0.01% | 2180 |
|
|
2017
Q1 | $43.1M | Buy |
1,335,539
+1,334,597
| +141,677% | +$33.3M | ﹤0.01% | 2316 |
|
|
2016
Q4 | $17K | Sell |
942
-154
| -14% | -$3.32K | ﹤0.01% | 3296 |
|
|
2016
Q3 | $25K | Buy |
1,096
+128
| +13% | +$2.91K | ﹤0.01% | 3237 |
|
|
2016
Q2 | $18K | Sell |
968
-569
| -37% | -$10.3K | ﹤0.01% | 3302 |
|
|
2016
Q1 | $28K | Buy |
1,537
+1,269
| +474% | +$20.4K | ﹤0.01% | 2680 |
|
|
2015
Q4 | $6K | Hold |
268
| – | – | ﹤0.01% | 3117 |
|
|
2015
Q3 | $5K | Hold |
268
| – | – | ﹤0.01% | 3047 |
|
|
2015
Q2 | $9K | Sell |
268
-72
| -21% | -$2.9K | ﹤0.01% | 2897 |
|
|
2015
Q1 | $16K | Hold |
340
| – | – | ﹤0.01% | 2481 |
|
|
2014
Q4 | $8K | Hold |
340
| – | – | ﹤0.01% | 2915 |
|
|
2014
Q3 | $6K | Hold |
340
| – | – | ﹤0.01% | 3037 |
|
|
2014
Q2 | $9K | Buy |
340
+135
| +66% | +$3.42K | ﹤0.01% | 2883 |
|
|
2014
Q1 | $7K | Buy |
205
+46
| +29% | +$1.5K | ﹤0.01% | 2961 |
|
|
2013
Q4 | $4K | Buy |
+159
| New | +$4.45K | ﹤0.01% | 3104 |
|
BlackRock's FMI Position: Q3 2018 in Review
BlackRock sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 1,465,265 shares — an estimated $200M sold.
BlackRock first reported a position in FMI in Q4 2013 and held it in 19 quarters. The position peaked at $200M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- BlackRock reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- BlackRock sold 1,465,265 Foundation Medicine, Inc. shares in Q3 2018, an estimated $200M.
- BlackRock first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 19 quarters.
- BlackRock's Foundation Medicine, Inc. position peaked at $200M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on BlackRock's 13F filing for Q3 2018, filed 9 Nov 2018.